Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Minoderm
Cannabinoids in the management of difficult to treat pain.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Acid-sensing ion channels: trafficking and synaptic function.
[Neuromyelitis optica.]
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis.
Value of NMO-IgG determination at the time of presentation as CIS.
[Autophagy and its role in protective and damaging inflammatory response].
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS.
Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Drug-induced thrombocytopenia secondary to natalizumab treatment.
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Treatment of NMO relapse in the elderly: rituximab when plasma exchange fails?
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand.
Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis.
Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Humoral mechanisms in T cell vaccination: induction and functional characterization of anti-lymphocytic autoantibodies.
Pages
« first
‹ previous
…
208
209
210
211
212
213
214
215
216
…
next ›
last »